Effectiveness of the Ecoguided Percutaneous Neuromodulation of the Multipurpose Musculature of L-3 in Non-specific Chronic Lumbar Pain.
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Low Back Pain
- Sponsor
- Universidad de Almeria
- Enrollment
- 70
- Locations
- 1
- Primary Endpoint
- Change from baseline in Roland Morris Disability Questionnaire (RMDQ)
- Status
- Completed
- Last Updated
- 11 months ago
Overview
Brief Summary
The study evaluates the effectiveness of Ultrasound-guided Percutaneous Neuromodulation in the lumbar multifidus of L3 in non-specific chronic low back pain.
Detailed Description
The effectiveness of neuromoduation in analgesic therapies has been more than contrasted. Considering that multifidus muscles, composed of the spinous transverse rotators muscles and spinous transverse multifidus muscles, are fundamental both for the static and for the dynamics of the lumbar spine, particularly for the region of L-3, the treatment of this musculature with ultrasound-guided percutaneous neuromodulation in patients with nonspecific chronic low back pain must have an analgesic repercussion in this nociceptive process. Therefore, given that neuromodulation has been considered as a more than effective treatment in painful symptomatology and that diverse scientific literature has proven the activity of the multifida musculature directly affects the stability and mobility of the lumbar spine, it is more than likely interventions with neuromodulative treatments in the multifidus musculature at the level of the third lumbar vertebrae have positive results in Non-specific Chronic Low Back Pain.
Investigators
Adelaida María Castro-Sánchez
PhD
Universidad de Almeria
Eligibility Criteria
Inclusion Criteria
- •Score ≥4 on the Roland Morris Disability Questionnaire.
- •Low back pain for ≥3 months
- •Age between 18 and 65 years
- •Not undergoing another physical therapy treatment
Exclusion Criteria
- •Presence of lumbar stenosis
- •Diagnosis of spondylolisthesis
- •Diagnosis of fibromyalgia
- •Treatment with corticosteroid or oral medication within the past two weeks
- •A history of spinal surgery
- •Contraindication of analgesic electrical therapy
- •Having previously received a treatment of electrical analgesia.
Outcomes
Primary Outcomes
Change from baseline in Roland Morris Disability Questionnaire (RMDQ)
Time Frame: At baseline and at 4 weeks (immediate post-treatment)
This is a self-reported questionnaire consisting in 24 ítems reflecting limitations in different activities of daily living attributed to low back pain including walking, vending over, sitting, lying down, dressing, sleeping, self-care and daily activities.
Secondary Outcomes
- Change from Mcquade Test(At baseline and at 4 weeks (immediate post-treatment))
- Change from baseline in lumbar mobility flexion(At baseline and at 4 weeks (immediate post-treatment))
- Change from baseline in pain intensity (Visual Analogue Scale).(At baseline and at 4 weeks (immediate post-treatment))
- Change from baseline on Quality of Life.(At baseline and at 4 weeks (immediate post-treatment))
- Change from baseline in disability. Oswestry Low Back Pain Disability Index (ODI).(At baseline and at 4 weeks (immediate post-treatment))
- Change from baseline in Fear of Movement. Tampa Scale of kinesiophobia.(At baseline and at 4 weeks (immediate post-treatment))
- Change from baseline in range of motion and lumbar segmental mobility(At baseline and at 4 weeks (immediate post-treatment))